Assertion: institute's program | /r/CapableOf | bridge process
Facets:
value: from scientific discovery
type: OTHER
value: through regulatory review
type: MANNER
Source sentences:
text: February 16, 2005—In preparation for the new generation of molecular-based oncology medical products and as an initiative of NCI’s and FDA's Interagency Oncology Task Force, the agencies jointly established an NCI-FDA Research and Regulatory Review Fellowship program, designed to train researchers to bridge the processes from scientific discovery through clinical development and regulatory review of new oncology products.